Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

June 01, 1999; 52 (9) Article

Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals

S. Claiborne Johnston, R. Adams Dudley, Daryl R. Gress, Linda Ono
First published June 1, 1999, DOI: https://doi.org/10.1212/WNL.52.9.1799
S. Claiborne Johnston
From the Neurovascular ServiceDepartment of Neurology (Drs. Johnston and Gress), Institute for Health Policy Studies (Dr. Dudley), and Department of Quality Improvement (L. Ono), University of California, San Francisco, CA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Adams Dudley
From the Neurovascular ServiceDepartment of Neurology (Drs. Johnston and Gress), Institute for Health Policy Studies (Dr. Dudley), and Department of Quality Improvement (L. Ono), University of California, San Francisco, CA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daryl R. Gress
From the Neurovascular ServiceDepartment of Neurology (Drs. Johnston and Gress), Institute for Health Policy Studies (Dr. Dudley), and Department of Quality Improvement (L. Ono), University of California, San Francisco, CA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Ono
From the Neurovascular ServiceDepartment of Neurology (Drs. Johnston and Gress), Institute for Health Policy Studies (Dr. Dudley), and Department of Quality Improvement (L. Ono), University of California, San Francisco, CA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals
S. Claiborne Johnston, R. Adams Dudley, Daryl R. Gress, Linda Ono
Neurology Jun 1999, 52 (9) 1799; DOI: 10.1212/WNL.52.9.1799

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
6

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective: To compare complications of surgical clipping and coil embolization in the treatment of unruptured aneurysms.

Background: Surgical clipping has been the preferred treatment for unruptured cerebral aneurysms but endovascular coil embolization is an increasingly employed alternative. No direct comparisons of the techniques are available to guide clinical decision making.

Methods: We performed a cohort study of patients treated for unruptured cerebral aneurysms at 60 university hospitals from January 1994 through June 1997 using the University HealthSystem Consortium database. The database was validated by chart review from one of the participant universities. The main outcome measures were in-hospital mortality and adverse outcomes, defined as in-hospital deaths and discharges to nursing homes or rehabilitation hospitals.

Results: The primary treatment modality was surgical in 2,357 cases and endovascular in 255 cases. Adverse outcomes were significantly more common in surgical cases (18.5%) compared to endovascular cases (10.6%) (p = 0.002), and the difference was not altered after adjusting for age, sex, race, transfer admissions, emergency room admissions, and year of treatment (odds ratio [OR] 2.1, 95% confidence interval [CI] 1.4 to 3.3; p = 0.001). In-hospital mortality was also increased in surgical cases (2.3% versus 0.4%; p = 0.039), but the difference was not significant in the multivariable model (OR 6.3, 95% CI 0.9 to 46.1; p = 0.07). Length of stay and hospital charges were significantly greater for surgical cases (p < 0.0001 for each), and these differences were not affected by risk adjustment.

Conclusion: Endovascular coil embolization resulted in fewer adverse outcomes than surgery for unruptured cerebral aneurysms treated at the university hospitals studied. Although these results should be seen as preliminary, the magnitude of difference and current predominance of surgery appear to justify a randomized trial.

In the United States, ruptured aneurysms account for nearly one third of years of potential life lost before age 65 among stroke causes.1 Based on relatively low rates of mortality and morbidity for surgical clipping reported in the literature,2 many physicians have recommended early treatment for all unruptured aneurysms.3-7

Neurosurgical clipping has been the standard approach to treatment of cerebral aneurysms.8 For unruptured aneurysms, surgical series have reported mortality of 0 to 6% and morbidity of 0 to 30%.2,9 However, a review of discharge data from New York state hospitals for 1987 to 1993 found higher in-hospital mortality rates, with 4.6% mortality in institutions performing more than 30 craniotomies per year and 8.1% in others,10 suggesting that the highly specialized surgical centers reporting case series may not be representative of the experience of the majority of hospitals.

Endovascular coil embolization (coiling) is a technique performed by neurointerventional radiologists in which aneurysms are occluded by deploying a series of platinum coils (Guglielmi detachable coils [GDC]) into the aneurysm sac through a catheter inserted into the femoral artery.11 The technique was introduced in 199112 and has become a more frequent alternative to surgical clipping.8,13 Case series have suggested that treatment-related complication rates are similar to those of surgery, with procedure-related morbidity 3.7% and mortality 1% in a recent meta-analysis.14 How coil embolization and surgical clipping compare in equivalent patients is unknown.

Comparing outcomes for ruptured aneurysm treatments is difficult because clinical factors, particularly the severity of the initial subarachnoid hemorrhage, are very strong predictors of outcome, obscuring effects owing to differences in the treatment modalities. Because unruptured aneurysm patients are often clinically stable and usually asymptomatic,15 clinical characteristics are less likely to hinder evaluation of treatment-related complications. For this reason, we have focused our evaluation on unruptured aneurysms, comparing morbidity and mortality of surgical clipping and coil embolization by analyzing data from 60 university medical centers after validating the database by chart review from one of the centers.

Methods.

The University Health System Consortium (UHC) is an organization of 80 health centers with involvement in medical education. UHC maintains a database of all hospital discharges for member hospitals that includes 2.1 million discharges per year.16 The UHC database was searched from January 1, 1994 to June 30, 1997 for primary diagnosis of unruptured cerebral aneurysm (ICD-9 437.3) and surgical clipping (ICD-9 procedure code 39.51) or repair by other means including coil embolization and wrapping (ICD-9 39.52). Sixty member universities contributed unruptured aneurysm cases to the database (see Appendix).

To determine the accuracy of coding in the UHC database, we compared a detailed review of records at the University of California, San Francisco (UCSF), the largest contributor to the database, with the coded data for the years 1994 to 1996. Cases of treated unruptured cerebral aneurysms were identified through computerized search of medical records and review of clinical databases in the Division of Neurointerventional Radiology and the Neurovascular Service. Medical records were reviewed independently by a clinical nurse specialist and one of the authors (S.C.J.), both blinded to UHC coding, and information on accuracy of diagnosis, procedure performed, length of stay, and discharge status were recorded. The Rankin Score at discharge was determined from record review. Charges were independently obtained through the hospital billing database.

Information from medical record review was compared with UHC data from the same patients, linking records by year of birth and medical record numbers. From this review (described below), strategies for reducing misclassification in the UHC analysis were developed.

Surgically wrapped aneurysms were occasionally coded with the ICD-9 code 39.52 used to identify endovascularly treated aneurysms. Because we were interested in comparing surgical with endovascular therapy, procedures were grouped by operating physician (figure), and cases coded as 39.52 in which the operating physician performed more than 50% surgical clippings (4.2% of total cases) were reanalyzed as surgical cases.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Patient categorization and selection. *Cases reclassified based on the predominant procedure type of the treating physician.

It is common for patients undergoing coiling to need follow-up embolization to obliterate the aneurysm completely (occurred in 11% of cases). Surgically treated patients need repeat procedures less often. Because follow-up procedures involve less risk than primary procedures, accurate comparison of the total risk for a treatment approach requires the linking of primary procedures to follow-up procedures (creating a single course of treatment). Failure to identify courses completely would bias results in favor of coiling. To correct this, all admissions for a given patient were clustered by sorting records by university hospital, year of birth, and medical record number (80% identity required). These records were then combined so that each represented the entire treatment course for unruptured aneurysms during the study period (see figure). For these combined entries (2.9% of total), length of stay and charges were taken as the sum of all hospitalizations, and discharge status was taken as the most adverse. In this way, multiple admissions for treatment of an unruptured aneurysm (occurring more commonly for coiled aneurysms) were treated as a single event with the most adverse consequence of treatment taken as discharge status. When two different treatments were undertaken, the first was coded as the primary procedure to parallel an intention-to-treat analysis.

An adverse outcome was defined as an in-hospital death or transfer to a nursing home or rehabilitation hospital at discharge. Patients admitted from nursing homes were excluded from analysis of discharge to rehabilitation hospitals or nursing homes as it was presumed they would return to these hospitals even if the procedure was uncomplicated.

Statistical analyses were performed using the Stata statistical package (version 5.0, Stata Corporation, College Station, TX). For univariate comparisons of continuous variables, we used Student’s t-test for normally distributed variables and Wilcoxon’s rank-sum test for skewed results (i.e., length of stay and hospital charges). For discrete variables, Fisher’s exact test was used for comparisons with a cell number less than 10 and Pearson’s chi-square test was used for all others. Multivariable analyses were performed with logistic regression for dichotomous outcomes and linear regression for continuous outcomes, including all admission variables in the model (age, sex, race, transfer admission, emergency room admission, and year). To account for the effects of the correlation between observations within a given university hospital, the generalized estimating equations approach was used for the logistic regression. Compound symmetry (equal correlation between all inter-center observations) was chosen as the covariance structure.17

Results.

Validation of database.

To validate the UHC database for the diagnosis of unruptured cerebral aneurysms, we compared an extensive chart review at UCSF with matching records in the UHC database. Chart review revealed 153 cases of treated unruptured aneurysms in the years 1994 through 1996, and 139 of these were also listed in the UHC database, indicating 91% case retrieval by UHC. The UHC database included 40 cases (22%) that were not primary attempts at treatment of unruptured aneurysms. Follow-up embolization for partially coiled aneurysms was the most common cause of this misclassification, accounting for 33 cases. Five cases were treatments for aneurysms that had ruptured more than 1 month before, one case was a carotid-cavernous fistula, and one case was an acute subarachnoid hemorrhage, Hunt and Hess grade 1. We combined all admissions for a given patient, taking the most adverse outcome and summing the length of stays and charges so that each outcome represented an entire course of therapy. This reduced the number of follow-up studies to 10 and the total number of improperly included cases to 17 (9%), but also meant that four cases, all coil embolizations, included treatments for two separate aneurysms, producing a small bias against coiling.

Procedure type was incorrectly specified in 4 of 179 cases (2%) listed in UHC, all cases of surgical aneurysm wrapping coded with the ICD-9 code we used to identify coiling. Classifying procedures by the majority of case types performed by a given operating physician properly identified the procedure type—surgical versus endovascular—for all UCSF cases in the UHC database, and presumably improved classification in the entire study cohort.

Charges given by UHC were within 1% of UCSF accounting records in 77 of 84 cases reviewed (92%) and within 5% in 79 (94%). Length of stay was within 1 day in 75 of 79 cases reviewed (95%). The Rankin Score at discharge from chart review was highly correlated with discharge to nursing home/rehabilitation hospital (R = 0.76, p < 0.0001 by Spearman rank correlation), with 5/5 patients with Rankin 4 (moderately severe disability) transferred, 3/7 with Rankin 3 (moderate disability) transferred, and 1/56 with Rankin 2 or less (slight disability or better) transferred. The single death at UCSF was correctly identified in the UHC database.

Surgical clipping and coil embolization in UHC.

Patients undergoing surgical clipping were younger and more likely to be African American and admitted from the emergency room (table 1). Patients treated with coil embolization were more often of Asian decent. There were no differences in gender, percent white, or portion of patients received in transfer from another hospital. There were more surgical clipping cases from the Southeastern United States and more coiling cases from the West Coast, likely accounting for the observed race differences. Forty-two hospitals did not offer coil embolization and 90% of endovascular cases were contributed by four institutions.

View this table:
  • View inline
  • View popup
Table 1.

Patient characteristics

Univariate analysis revealed significantly higher in-hospital mortality rates and adverse outcomes, defined by death or discharge to nursing home or rehabilitation hospital, in the patients treated by surgical clipping compared with coil embolization (table 2). Multivariable analysis was performed with all available potential confounding variables. After adjustment for age, sex, race, admission by transfer, admission from the emergency room, and year of procedure, a twofold excess in odds of an adverse event remained (table 3). With the same multivariable model, the odds ratio (OR) of in-hospital mortality remained highly elevated at 6.3 for surgically treated patients, but it was no longer statistically significant (95% confidence interval [CI] 0.9 to 46.1; p = 0.07) (see table 3). Limiting the multivariable models to variables with significant contribution to the model did not alter these conclusions.

View this table:
  • View inline
  • View popup
Table 2.

Univariate analysis

View this table:
  • View inline
  • View popup
Table 3.

Multivariable analysis

Mean length of stay and total hospital charges for initial and any follow-up admissions were significantly greater for clipped patients (see table 2), and the differences were persistent after adjustment for potential confounders (see table 3).

Sensitivity analysis.

Because the proportion of patients admitted from the emergency room was significantly different between the groups, we repeated the univariate analysis with these patients excluded (see table 2). This did not alter the strength or direction of the findings. Also, including the effect of clustering by hospital on the variance did not alter the conclusions (data not shown).

The reclassification scheme was meant to move surgically wrapped aneurysms from the endovascular category and correct miscoding of procedure in coiled cases by classifying patients according to the primary procedure performed by the operating physician. To see how this scheme affected the overall results, all reclassified cases (n = 123) were excluded, producing a truer comparison of endovascular coiling to surgical clipping rather than surgical therapy by eliminating the surgically wrapped patients. Higher relative risks for surgery were found with OR 2.3 (95% CI 1.5 to 3.6; p < 0.001) for adverse outcomes in the clipping group by univariate analysis and OR 2.6 (95% CI 1.6 to 4.2; p < 0.001) in the multivariable model. The risk of in-hospital death remained elevated for surgery with results similar to the overall analysis (univariate OR 6.1, 95% CI 1.0 to 44.7, p = 0.038; multivariable OR 6.2, 95% CI 0.8 to 45.8, p = 0.07).

Discussion.

The findings of this study must be viewed with several limitations in mind, shared by other analyses of large, retrospective, multipurpose databases. First, there is a potential problem with misclassification of the outcomes, the procedures, and the covariates. We have tried to reduce this problem by comparing a subset of the data with detailed medical record review, and subsequently altering variable definitions to reduce misclassification. Certainly, there is residual misclassification, and it may be that UCSF data in the UHC database is better than the data provided by other institutions. Nonetheless, based on our record review at UCSF, we believe that misclassification is not a major problem when all admissions for a given patient are considered a single treatment course and when procedure is defined by the predominant procedure of the operating physician.

Second, the outcome variables have several important limitations. For this study, the only available clinical outcome variables were in-hospital mortality and transfer to a nursing home or rehabilitation facility. Transfer to another facility at discharge was highly correlated with disability at time of discharge assessed by Rankin Score from hospital record review. However, surgically clipped patients may recover more slowly but more completely, and this would not be apparent in our analysis. Nevertheless, the outcomes are clearly defined, reliable, and probably important, providing an initial insight into differences between treatment complications.

Third, there may be inadequate control of important confounding variables.18 Patients treated with surgical clipping may have more comorbid disease, larger aneurysms, or more acute compressive symptoms than those treated endovascularly. We included all available potential risk factors for poor outcome in the multivariable models, including age, gender, race, and admission source (emergency room, transfer, or elective), but other potentially important risk factors could not be controlled because they were not available in the database. Because many patients with unruptured aneurysms are asymptomatic and tend to by younger (average age 52 in this study), patient characteristics may be less important as confounders, but aneurysm characteristics may have influenced decisions about which treatment to employ and could have important effects on the outcomes.15,19 However, treatment decisions appeared to be dictated more by institutional preference than case-specific characteristics, as coil embolization was not offered at many institutions and predominated at a few, and this would tend to reduce selection bias.

Fourth, studies of this type can only track events that occur during hospitalization. Therefore, the success of therapy in terms of reduction in aneurysm rupture rates cannot be measured. It is possible that endovascular coil embolization is ineffective at treating aneurysms, and this would not be apparent from our data. However, reported rates of rupture in the literature have been extremely low for unruptured aneurysms treated by surgical clipping7,15 and coil embolization.20-22 Given recent data from the International Study of Unruptured Intracranial Aneurysms suggesting rupture rates are much lower than previously believed,23 this might be expected even with ineffective treatment. More persuasively, however, ruptured aneurysms also have very low rerupture rates after treatment with either modality,21,24-29 supporting the effectiveness of both therapies because aneurysm rerupture rates are high.30 Therefore, defining perioperative complications may be more important for planning treatment.

Despite the limitations of this study, the finding of relatively low risks of in-hospital mortality and discharge to nursing home or rehabilitation facility for endovascularly treated compared to surgically treated unruptured aneurysms is dramatic and provocative. Also, the study has advantages over the case series reported in the literature. By comparing these two treatment modalities head-to-head and performing risk adjustment, we can be more confident that differences in definitions of potential confounders and outcomes are not responsible for the observed effect. In addition, we have removed a potential bias of practicing physicians to underestimate important complications. Finally, centers that do not specialize in these procedures are included, providing a more realistic estimate of the performance of these techniques in the community. However, it was necessary to focus the analysis on academic medical centers because endovascular coil embolization is rarely performed outside this setting; nontertiary hospitals have higher mortality rates for aneurysm surgery10 and including them could have negatively biased our assessment of surgery.

Our results are similar to those reported in the literature. A recent meta-analysis of studies published between 1966 and 1996 on clipping of unruptured aneurysms found an overall mortality of 2.6%,9 very close to the 2.3% found in this study. Morbidity was 10.9% in a meta-analysis,9 lower than the 18.5% adverse outcome rate we found, but this difference may simply be due to more strict definitions of complications in the studies included in the meta-analysis. Some studies have defined morbidity as a permanent deficit or disability with dependence, neither of which is necessary in our definition of adverse outcome, defined as in-hospital death or discharge to a nursing home or rehabilitation hospital. For endovascular coil embolization, fewer data are available in the literature. For unruptured aneurysms, small case series have demonstrated mortality of 0 to 12% and morbidity 0 to 16%, with the higher rates in patients who had failed surgical attempts.20-22,31 A more recent case series of 187 subarachnoid hemorrhage cases without neurologic deficits on presentation found 0.5% mortality and 7.5% deterioration in coiled patients,28 more similar to the 0.4% mortality and 10.6% adverse outcomes we found in unruptured aneurysms. Less experience with the technique and selection of more difficult cases for coiling may account for the differences in the earlier series.

This study suggests that perioperative mortality and need for rehabilitation/nursing home transfer at discharge are lower for unruptured aneurysm patients treated by endovascular coiling compared with surgical clipping. Hospital charges and length of stay were also significantly lower in the endovascular cases. The results must be interpreted with caution because of the nature of the study. Rather than providing evidence for recommending coil embolization, the results should be seen as further impetus to compare the pervasive treatment modality, surgical clipping, with the new technology of endovascular coil embolization. Clearly, more definitive data are required with studies comparing these therapies in patients who could have received either treatment, either randomizing patients to clipping versus coiling or, if randomization is not possible, adjusting for all known potential risk factors including patient comorbidities and aneurysm location and size.

Appendix

The following institutions, in alphabetical order by state, contributed unruptured aneurysm cases to the database:

University of Alabama, University of Southern Alabama; University of Arizona; University of Arkansas; University of California Davis, UCLA, UCSD, UCSF, Stanford; University of Colorado; Yale; Georgetown; University of Florida; Emory University; Medical College of Georgia; Loyola University, University of Chicago, University of Illinois at Chicago; Indiana University; University of Iowa; University of Kansas; University of Kentucky; University of Massachusetts; University of Michigan; Fairview University of Minnesota; University of Missouri, St. Louis University; University of Nebraska; Robert Wood Johnson University; Columbia-Presbyterian, New York University, SUNY Brooklyn, SUNY Syracuse, SUNY Stony Brook; University of Eastern Carolina, University of North Carolina, Wake Forest; Medical College of Ohio, Ohio State University, University of Cincinnati, Case Western Reserve; University of Oklahoma; Oregon Health Sciences University; Allegheny University, University of Pennsylvania, Pennsylvania State University, University of Pittsburgh, Thomas Jefferson University, Lehigh Valley; Medical University of South Carolina; Vanderbilt; Memorial Hermann Hospital, University of Texas, Galveston; University of Utah; Medical College of Virginia, University of Virginia; University of Washington; West Virginia University; Froedtert Memorial Hospital, University of Wisconsin.

Footnotes

  • See also page 1806

  • S.C.J. is a Research Fellow of the National Stroke Association and is supported by the NIH/NINDS (K08 NS 02042-01).

  • Received January 18, 1999.
  • Accepted in final form March 20, 1999.

References

  1. ↵
    Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998;50:1413–1418.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    King JT Jr, Berlin JA, Flamm ES. Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms : a meta-analysis. J Neurosurg 1994;81:837–842.
    OpenUrlCrossRefPubMed
  3. ↵
    King JT Jr, Glick HA, Mason TJ, Flamm ES. Elective surgery for asymptomatic, unruptured, intracranial aneurysms : a cost-effectiveness analysis. J Neurosurg 1995;83:403–412.
    OpenUrlPubMed
  4. van Crevel H, Habbema JD, Braakman R. Decision analysis of the management of incidental intracranial saccular aneurysms. Neurology 1986;36:1335–1339.
    OpenUrlAbstract/FREE Full Text
  5. Chang HS, Kirino T. Quantification of operative benefit for unruptured cerebral aneurysms : a theoretical approach. J Neurosurg 1995;83:413–420.
    OpenUrlCrossRefPubMed
  6. Leblanc R, Worsley KJ. Surgery of unruptured, asymptomatic aneurysms : a decision analysis. Can J Neurol Sci 1995;22:30–35.
    OpenUrlPubMed
  7. ↵
    Wirth FP, Laws ER Jr, Piepgras D, Scott RM. Surgical treatment of incidental intracranial aneurysms. Neurosurgery 1983;12:507–511.
    OpenUrlCrossRefPubMed
  8. ↵
    Schievink WI. Intracranial aneurysms. N Engl J Med 1997;336:28–40.
    OpenUrlCrossRefPubMed
  9. ↵
    Raaymakers TW, Rinkel GJ, Limburg M, Algra A. Mortality and morbidity of surgery for unruptured intracranial aneurysms : a meta-analysis. Stroke 1998;29:1531–1538.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Solomon RA, Mayer SA, Tarmey JJ. Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality. Stroke 1996;27:13–17.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Guglielmi G, Vinuela F, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach. Part 1 : electrochemical basis, technique, and experimental results. J Neurosurg 1991;75:1–7.
    OpenUrlCrossRefPubMed
  12. ↵
    Guglielmi G, Vinuela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach. Part 2 : preliminary clinical experience. J Neurosurg 1991;75:8–14.
    OpenUrlCrossRefPubMed
  13. ↵
    Bryan RN, Rigamonti D, Mathis JM. The treatment of acutely ruptured cerebral aneurysms : endovascular therapy versus surgery. AJNR Am J Neuroradiol 1997;18:1826–1830.
    OpenUrlPubMed
  14. ↵
    Brilstra EH, Rinkel GJE, van der Graaf Y, van Rooij WJJ, Algra A. Treatment of intracranial aneurysms by embolization with coils : a systemic review. Stroke 1999;30:470–476.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Solomon RA, Fink ME, Pile-Spellman J. Surgical management of unruptured intracranial aneurysms. J Neurosurg 1994;80:440–446.
    OpenUrlCrossRefPubMed
  16. ↵
    Member Statistics. In: University Health Systems Consortium, 1998. http://www.uhc.edu/about/memstats.html
  17. ↵
    Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford Statistical Science Series, vol. 13. Oxford: Clarendon Press, 1994.
  18. ↵
    Poses RM, Smith WR, McClish DK, Anthony M. Controlling for confounding by indication for treatment. Are administrative data equivalent to clinical data? Med Care 1995;33 (suppl 4):AS36–AS46.
    OpenUrlPubMed
  19. ↵
    Khanna RK, Malik GM, Qureshi N. Predicting outcome following surgical treatment of unruptured intracranial aneuhrysms : a proposed grading system. J Neurosurg 1996;84:49–54.
    OpenUrlCrossRefPubMed
  20. ↵
    Guglielmi G, Vinuela F, Duckwiler G,et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg 1992;77:515–524.
    OpenUrlCrossRefPubMed
  21. ↵
    Malisch TW, Guglielmi G, Vinuela F, et al. Intracranial aneurysms treated with the Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. J Neurosurg 1997;87:176–183.
    OpenUrlCrossRefPubMed
  22. ↵
    Halbach VV, Higashida RT, Dowd CF, et al. The efficacy of endosaccular aneurysm occlusion in alleviating neurological deficits produced by mass effect. J Neurosurg 1994;80:659–666.
    OpenUrlCrossRefPubMed
  23. ↵
    The International Study of Unruptured Intracranial Aneurysms Investigators.Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med 1998;339:1725–1733.
    OpenUrlCrossRefPubMed
  24. ↵
    Drake CG, Vanderlinden RG. The late consequences of incomplete surgical treatment of cerebral aneurysms. J Neurosurg 1967;27:226–238.
    OpenUrlCrossRefPubMed
  25. Graves VB, Strother CM, Duff TA, Perl J. II. Early treatment of ruptured aneurysms with Guglielmi detachable coils : effect on subsequent bleeding. Neurosurgery 1995;37:640–647.
    OpenUrlCrossRefPubMed
  26. Casasco AE, Aymard A, Gobin YP, et al. Selective endovascular treatment of 71 intracranial aneurysms with platinum coils. J Neurosurg 1993;79:3–10.
    OpenUrlCrossRefPubMed
  27. Jane JA, Kassell NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg 1985;62:321–323.
    OpenUrlCrossRefPubMed
  28. ↵
    Vinuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm : perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997;86:475–482.
    OpenUrlCrossRefPubMed
  29. ↵
    McDougall CG, Halbach VV, Dowd CF, Higashida RT, Larsen DW, Hieshima GB. Endovascular treatment of basilar tip aneurysms using electrolytically detachable coils. J Neurosurg 1996;84:393–399.
    OpenUrlCrossRefPubMed
  30. ↵
    Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1 : overall management results. J Neurosurg 1990;73:18–36.
    OpenUrlCrossRefPubMed
  31. ↵
    Eskridge JM, Song JK. Endovascular embolization of 150 basilar tip aneurysms with Guglielmi detachable coils : results of the Food and Drug Administration multicenter clinical trial. J Neurosurg 1998;89:81–86.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Appendix
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • Which unruptured cerebral aneurysms should be treated?A cost–utility analysis

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise